Trelegy vs Symbicort
What to choose Trelegy or Symbicort
Trelegy is inhaler of type Control while Symbicort is of Control type. Trelegy and Symbicort are both brand inhalers. Trelegy is manufactured by pharmaceutical company GSK, while Symbicort is manufactured by AstraZeneca. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6.
The average price for Trelegy is roughly $619.92 while average cost for Symbicort is around $359, said Damian Scott, a Research Assistant at the Purdue University Calumet and a Surgeon at a clinic that uses Trelegy and Symbicort.
Trelegy and Symbicort Comparison
| Trelegy | Symbicort | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | GSK | AstraZeneca |
| Substance: | Fluticasone + Vilanterol | Budesonide + Formoterol |
| Dosage: | 100 mcg / 25 mcg | 100/6, 160/4.5, 200/6, 400/6 |
| Avg Price: | $619.92 | $359 |